Should all private hospitals be required to publicly disclose the cost of treatments and medications to patients?
Recent reports of exorbitant medical costs have raised concerns about the affordability of healthcare in India. The National Pharmaceutical Pricing Authority (NPPA) has called for greater transparency in medical costs to prevent patient exploitation, but the healthcare industry argues that such measures could stifle innovation and drive up costs.
Increased transparency in treatment costs could help patients make informed decisions and reduce unnecessary medical expenses. However, the industry's fear of price wars and the potential impact on medical research and innovation need to be considered.
Join the discussion on MIG
Sign in with GoogleNo comments yet.
Start the civic conversation above!